Samples were processed and analyzed as previously described
12 (link) with minor modifications as indicated below:
RNA was extracted from Trizol-lysed cells and 1 μg of total RNA was used for each sample. Polyadenylated RNA was selected using
Ambion Dynabeads mRNA Purification Kit (Life Technologies 61006) and fragmented with
Fragmentation Buffer (Ambion, #AM8740). First strand synthesis was performed using
Random Hexamer Primers (Invitrogen, #48190-011) and
SuperScript II (Invitrogen, #18064-014). Second strand synthesis was performed using
DNA Pol I (Invitrogen #18010-025) and RNA was removed using
RNaseH (Invitrogen #18021-014).
Libraries were end-repaired, 3′ A-tailed, and ligated to NEBNext Multiplex Oligo Adaptors (NEB E7335S). Sequencing was performed on an Illumina
NextSeq 500 by Stanford Functional Genomics Facility.
Reads were mapped to hg19 annotation using Tophat2
38 (link) (version 2.0.13) and transcript expression was quantified against RefSeq gene annotations using featureCounts
39 (link). Differential testing and log2 fold change calculation was performed using DESeq2
40 (link) with default multiple hypothesis adjustment to reduce false positives (Benjamini-Hochberg, FDR = 0.1). Gene Ontology analyses were performed using DAVID
41 (link),42 (link).
Venkatesh H.S., Tam L.T., Woo P.J., Lennon J., Nagaraja S., Gillespie S.M., Ni J., Duveau D.Y., Morris P.J., Zhao J.J., Thomas C.J, & Monje M. (2017). Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature, 549(7673), 533-537.